Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrinology

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EN.2006-1232PMID 17234710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression.

  2007cited by this paper
• Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats.

  2006cited by this paper
• GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

  2006cited by this paper
• The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.

  2006cited by this paper
• Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function.

  2006cited by this paper
• Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

  2005cited by this paper
• GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.

  2005cited by this paper
• Tales beyond the crypt: glucagon-like peptide-2 and cytoprotection in the intestinal mucosa.

  2005cited by this paper
• Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

  2005cited by this paper
• Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.

  2005cited by this paper
• Proglucagon-derived peptides: mechanisms of action and therapeutic potential.

  2005cited by this paper
• Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.

  2005cited by this paper
• Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation.

  2005cited by this paper
• Brain-gut axis and its role in the control of food intake.

  2004cited by this paper
• Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin.

  2004cited by this paper
• Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.

  2004cited by this paper
• GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.

  2003cited by this paper
• Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.

  2003cited by this paper
• Glucagon-like peptide-2 and intestinal adaptation: an historical and clinical perspective.

  2003cited by this paper
• Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.

  2003cited by this paper
• Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.

  2003cited by this paper
• Alterations in enterocyte proliferation and apoptosis accompany TPN-induced mucosal hypoplasia and IGF-I-induced hyperplasia in rats.

  2002cited by this paper
• Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

  2002cited by this paper
• The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats.

  2002cited by this paper
• Modulation of specific intestinal epithelial progenitors by enteric neurons

  2001cited by this paper
• Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

  2001cited by this paper
• The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake

  2000cited by this paper
• Functional and chemical anatomy of the afferent vagal system.

  2000cited by this paper
• Enteroendocrine localization of GLP-2 receptor expression in humans and rodents.

  2000cited by this paper
• Maintaining Gut Integrity During Parenteral Nutrition of Tumor-Bearing Rats: Effects of Glucagon-Like Peptide 2

  2000cited by this paper
• Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems.

  1999cited by this paper
• Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.

  1999cited by this paper
• Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.

  1999cited by this paper
• Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2.

  1997cited by this paper
• Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release.

  1993influential reference
• Expression of c-fos protein in brain: metabolic mapping at the cellular level.

  1988influential reference
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats.

  1975cited by this paper
• Role of oral intake in maintenance of gut mass and disaccharide activity.

  1974cited by this paper

• Longitudinal single-cell analysis of glucagon-like peptide-2 treatment in patients with short bowel syndrome

  2025cites this paper
• Intestinal adaptation to cold-induced metabolic demand and feeding requires GLP-1R and GLP-2R signalling

  2025cites this paper
• Glucagon-like Peptide-2 Acts Partially Through Central GLP-2R and MC4R in Mobilizing Stored Lipids from the Intestine

  2025cites this paper
• Proglucagon-derived Peptides: Human Physiology and Therapeutic Potential.

  2025cites this paper
• Identification of Pappalysin-2 (PAPP-A2), a modulator of Insulin-like Growth Factor-1 pathway, as a potential marker of teduglutide efficacy in patients with short bowel syndrome.

  2025cites this paper
• GLP-2 regulation of intestinal lipid handling

  2024cites this paper
• GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice.

  2024cites this paper
• Glucagon-Like-Peptide-2 Stimulates Lacteal Contractility and Enhances Chylomicron Transport in the Presence of an Intact Enteric Nervous System

  2024cites this paper
• The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut–Brain Axis

  2024cites this paper
• Functional engineering of human iPSC‐derived parasympathetic neurons enhances responsiveness to gastrointestinal hormones

  2023cites this paper
• Release of Lipids Stored in the Intestine by Glucagon-Like Peptide-2 Involves a Gut-Brain Neural Pathway

  2023cites this paper
• Glucagon-like peptide-2 mobilization of intestinal lipid does not require canonical enterocyte chylomicron synthetic machinery.

  2022cites this paper
• Glucagon-like peptide-2 acutely enhances chylomicron secretion in humans without mobilizing cytoplasmic lipid droplets.

  2022cites this paper
• Lymphatics - not just a chylomicron conduit

  2022cites this paper
• Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery

  2022cites this paper
• Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract

  2021cites this paper
• Complementary and antagonistic effects of combined glucagon-like peptide-2 and glucagon-like peptide-1 receptor agonist administration on parameters relevant to short bowel syndrome.

  2021cites this paper
• MECHANISMS IN ENDOCRINOLOGY: The gut–brain axis: regulating energy balance independent of food intake

  2021cites this paper
• Physiological Role of Intestinotropic Glucagon Like Peptides in Health and Disease

  2021cites this paper
• Multi-organ coordination of lipoprotein secretion by hormones, nutrients and neural networks.

  2021cites this paper
• New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases

  2021cites this paper
• Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

  2020cites this paper
• Control of Intestinal Epithelial Proliferation and Differentiation: The Microbiome, Enteroendocrine L Cells, Telocytes, Enteric Nerves, and GLP, Too

  2019cites this paper
• Neuropods

  2019cites this paper
• Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms.

  2019cites this paper
• Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD

  2019cites this paper
• GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.

  2018cites this paper
• Effects of centrally administered glucagon-like peptide-2 on blood pressure and barosensitive neurons in spontaneously hypertensive rats.

  2018cites this paper
• Effects of intracerebroventricularly injected glucagon-like peptide-2 on ethanol-induced gastric mucosal damage in rats

  2018influential citation
• Hypothalamic Integration of the Endocrine Signaling Related to Food Intake.

  2018cites this paper
• Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function.

  2018cites this paper
• Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats.

  2018cites this paper
• Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications

  2018cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2017cites this paper
• Effect of porcine glucagon‐like peptides‐2 on tight junction in GLP‐2R + IPEC‐J2 cell through the PI3k/Akt/mTOR/p70S6K signalling pathway

  2017cites this paper
• Central and peripheral control of food intake

  2017cites this paper
• Inhibition of sweet chemosensory receptors alters insulin responses during glucose ingestion in healthy adults: a randomized crossover interventional study.

  2017cites this paper
• Glucagon-like peptide 2 and its beneficial effects on gut function and health in production animals.

  2016cites this paper
• GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.

  2016cites this paper
• GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity.

  2016cites this paper
• The Function of Intestinal Afferent Neurons in Regulating Satiety During Health and Obesity

  2016cites this paper
• Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet

  2016cites this paper
• Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats.

  2015cites this paper
• Oral and intestinal sweet and fat tasting: impact of receptor polymorphisms and dietary modulation for metabolic disease.

  2015cites this paper
• GLP‐2 as Beneficial Factor in the Glucose Homeostasis in Mice Fed a High Fat Diet

  2015cites this paper
• The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine.

  2015cites this paper
• Glucagon-like Peptide-2 Functions as an Anorexigenic Peptide not only in the Central Nervous System but also in the Peripheral Circulation in Broiler Chicks

  2015cites this paper
• Effects of centrally injected glucagon-like peptide-2 on gastric mucosal blood flow in rats: possible mechanisms.

  2015cites this paper
• Investigation of the role of pharmacokinetics and the development of novel anti-obesity agents

  2015influential citation
• Neuroimaging of gut nutrient perception.

  2014cites this paper
• Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.

  2014cites this paper
• Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

  2014cites this paper
• GLP-2: what do we know? What are we going to discover?

  2014cites this paper
• Animal Models of Infant Short Bowel Syndrome

  2014cites this paper
• Feeding-dependent activation of enteric cells and sensory neurons by lymphatic fluid: evidence for a neurolymphocrine system.

  2014cites this paper
• Award from the Neural Control and Autonomic Regulation ( NCAR ) Section of the American Physiological Society The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis

  2014cites this paper
• The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

  2014influential citation
• Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons.

  2013cites this paper
• Characterization of the hypotensive effects of glucagon-like peptide-2 in anesthetized rats.

  2013cites this paper
• Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.

  2013cites this paper
• Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.

  2013cites this paper
• Review article: a comparison of glucagon‐like peptides 1 and 2

  2013cites this paper
• A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes

  2013cites this paper
• Obesity and Appetite Control

  2012cites this paper
• Perinatal programming of appetite regulation and metabolic health

  2012cites this paper
• Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis

  2012cites this paper
• Intraportal administration of DPP‐IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats

  2012cites this paper
• double knockout mice intestinal response in IGF binding protein-3 and -5 Exogenous GLP-2 and IGF-I induce a differential

  2012cites this paper
• GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility.

  2012cites this paper
• The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides

  2012cites this paper
• Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2.

  2012cites this paper
• The glucagon-like Peptide-2 Flava Mulé

  2012cites this paper
• Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.

  2012cites this paper
• Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.

  2012cites this paper
• Immunohistochemical determination of the site of hypotensive effects of glucagon-like peptide-2 in the rat brain.

  2012influential citation
• Glucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway.

  2011cites this paper
• GLP‐2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility

  2011cites this paper
• The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

  2011influential citation
• Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts.

  2011cites this paper
• Glucagon-like peptide-2（GLP-2）と小腸の消化・吸収

  2011cites this paper
• Enteroendocrine peptides in intestinal inflammation

  2011cites this paper
• The glucagon-like Peptide-2

  2011cites this paper
• The Role of the GLP-2 Receptor in Intestinal and Islet Adaptation to Changes in Nutrient Availability

  2011cites this paper
• Neural regulation of intestinal nutrient absorption.

  2011cites this paper
• ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

  2010cites this paper
• GLP-2 Receptor Agonism Ameliorates Inflammation and Gastrointestinal Stasis in Murine Postoperative Ileus

  2010cites this paper
• The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes

  2010cites this paper
• Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

  2010cites this paper
• Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

  2010cites this paper
• Chronic effect of vagotomy in the morphometry of the myenteric plexus of rats' duodenum

  2010cites this paper
• The role of gut hormones and the hypothalamus in appetite regulation.

  2010cites this paper
• CHRONIC EFFECT OF VAGOTOMY IN THE MORPHOMETRY OF THE MYENTERIC PLEXUS OF RATSDUODENUM Efeito crônico da vagotomia sobre a morfometria do plexo mioentérico do duodeno de ratos

  2010cites this paper
• The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts

  2010cites this paper
• The versatility of the vagus.

  2009cites this paper
• Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.

  2009cites this paper
• ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.

  2009cites this paper
• Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways.

  2009cites this paper
• Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice.

  2009cites this paper
• Synergistic Effect of Glucagon-Like Peptide 2 (GLP-2) and of Key Growth Factors on the Proliferation of Cultured Rat Astrocytes. Evidence for Reciprocal Upregulation of the mRNAs for GLP-2 and IGF-I Receptors

  2009cites this paper
• IDENTIFICATION AND CHARA CTERIZATION OF THE GLUCAGON-LIKE PEPTIDE-2 HORMONAL SYSTEM IN RUMINANTS

  2009influential citation